Raghava Kurup R, Oakes EK, Manning AC, Mukherjee P, Vadlamani P and
Hundley HA (2022)
RNA binding by ADAR3 inhibits adenosine-to-inosine editing and promotes expression of the immune response protein MAVS,
JBC, 2022 Jul 15:102267. doi: 10.1016/j.jbc.2022.102267.
Ray U, Jung DB, Jin L, Xiao Y, Dasari S (TT), Sarkar Bhattacharya S, Thirusangu P, Staub JK, Roy D, Roy B, Weroha SJ, Hou X, Purcell JW, Bakkum-Gamez JN, Kaufmann SH, Kannan N, Mitra AK , Shridhar V. Targeting LRRC15 Inhibits Metastatic Dissemination of Ovarian Cancer. Cancer Res. 2022 MAR 15; 82(6):1038-1054. DOI: 10.1158/0008-5472.CAN-21-0622. PubMed PMID: 34654724; PMCID: PMC8930558.
Kumar B, Adebayo AK, Prasad M, Capitano ML, Wang R, Bhat-Nakshatri P, Anjanappa M, Simpson E, Chen D, Liu Y, Schilder JM, Colter AB, Maguire C, Temm CJ, Sandusky G, Doud EH, Wijeratne AB, Mosley AL, Broxmeyer HE and Nakshatri H. (2022). Tumor collection/processing under physioxia uncovers highly relevant signaling networks and drug sensitivity. Science Advances 8:eabh3375. Impact factor 14.2
Su X, et al. PCNA inhibition enhances the cytotoxicity of β-lapachone in NQO1-Positive cancer cells by augmentation of oxidative stress-induced DNA damage. Cancer Lett. 2021 Oct 28;519:304-314.
Wilson DM 3rd, et al. Fragment- and structure-based drug discovery for developing therapeutic agents targeting the DNA Damage Response. Prog Biophys Mol Biol. 2021 Aug;163:130-142.
Gampala S, Shah F, Lu X, Moon H, Babb O, Ganesh NU, Sandusky. G, Hulsey E, Armstrong, L, Mosely AL, Han B, Ivan M, Yeh J-R J, Kelley MR, Zhang C^, Fishel ML^. Ref-1 redox activity alters cancer cell metabolism in pancreatic cancer: Exploiting this novel finding as a potential target. J Exp Clin Cancer Res (2021) 40: https://doi.org/10.1186/s13046-021-02046-x. PMID: 34376225 ^Co-corresponding authors
Miller SA, et al. LSD1 and Aberrant DNA Methylation Mediate Persistence of Enteroendocrine Progenitors That Support BRAF-Mutant Colorectal Cancer. Cancer Res. 2021 Jul 15;81(14):3791-3805.
Chahoud J, Gleber-Netto FO, McCormick BZ, Rao P, Lu X, Guo M, Morgan MB, Chu RA, Martinez-Ferrer M, Eterovic AK, Pickering CR, Pettaway CA. Whole Exome Sequencing in Penile Squamous Cell Carcinoma Uncovers Novel Prognostic Categorization and Drug Targets Similar to Head and Neck Squamous Cell Carcinoma. Clin Cancer Res. 2021 May 1;27(9):2560-2570. doi: 10.1158/1078-0432.CCR-20-4004. Epub 2021 Jan 13. PubMed PMID: 33441293.
Sun X, Li K, Zha R, Liu S, Fan Y, Wu D, Hase M, Aryal UK, Lin CC, Li BY, Yokota H.Theranostics. Preventing tumor progression to the bone by induced tumor-suppressing MSCs. 2021 Mar 5;11(11):5143-5159. doi: 10.7150/thno.58779. eCollection 2021.PMID: 33859739
Greulich, B.M., Plotnik, J.P., Jerde, T.J., and P.C. Hollenhorst (2021). Toll-like receptor 4 signaling activates ERG function in prostate cancer and provides a therapeutic target. NAR Cancer 3(1): zcaa046.
Heather Hundley, PhD- 2023 RNA Editing Gordon Research Conference
- 2022 Bioorganic Chemistry Gordon Research Conference
Hari Nakshatri, BVSc, PhD
- Invited speaker at the 15th AACR Conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved. Philadelphia, September 16-19, 2022.
Edward Greenfield, PhD
Richard Carpenter, MD
- Jacobs CL, Sha SV, Lu WC, Ray H, Carpenter RL. HSF1 downregulation of CCL5 reduces CD8+ T cell trafficking in breast cancer. AACR Annual Meeting 2022. 04/2022. New Orleans, LA. Oral Presentation.
